home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,025 rows where filing_year = 2012 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • second_quarter 260
  • third_quarter 260
  • first_quarter 258
  • fourth_quarter 247

issue_code 1

  • MED · 1,025 ✖

filing_year 1

  • 2012 · 1,025 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1222637 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) e17fec05-b3ce-4b41-8ecc-bb82627cbd65 Q1 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 VIJUK EQUIPMENT, INC. 2012 first_quarter MED any issue relating to pharmaceutical labeling   25000   0 0 2012-03-30T10:49:56.770000-04:00
1222691 UNIVERSITY OF IOWA 8b9cb3b0-199e-49de-a24f-ac185760a0b2 Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2012 first_quarter MED FY 2011 Appropriations Residency Caps FY 2012 Appropriations Minority Improvement Medical Affordability Act False Claims Correction Act Research Misconduct Clinical Trials NIOSH Education and Research Centers for Occupational Health and Safety Pathways for Biosimilars Act Prevention Research Centers Resident Physician Shortage Health Care Reform Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   88684 0 0 2012-04-02T10:31:37.897000-04:00
1222715 MARSHALL BRACHMAN 02096854-f368-4afe-a8ff-fef756770e01 Q1 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2012 first_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2012-04-02T10:48:47.033000-04:00
1222953 GRIZZLE COMPANY b4da78dc-63b8-4f68-b921-ebbd79788d02 Q1 GRIZZLE COMPANY 16987 UNIVERSITY OF LOUISVILLE 2012 first_quarter MED Request support for NIH grant application HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-04-02T16:16:53.483000-04:00
1223552 HEALY STRATEGIES 4667272d-6d6f-47a3-bc46-ad13a7a18604 Q1 HEALY STRATEGIES 311495 UNIVERSITY OF MARYLAND MEDICAL SYSTEM 2012 first_quarter MED The Prescription Drug User Fee Act (PDUFA), drug shortages SENATE     0 0 2012-04-05T10:36:32.170000-04:00
1224052 WAKE FOREST UNIVERSITY HEALTH SCIENCES 1a8f0256-c349-4254-9e04-cc00e5a53e3b Q1 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2012 first_quarter MED NIH Budget including Title VII & VIII programs VA-Outpatient Clinic in N.C.(RFP-land acquisition) Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   160000 0 0 2012-04-09T10:43:32.813000-04:00
1224155 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 9f4a4a6b-fcd4-4180-9ae4-c0ade8f96421 Q1 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2012 first_quarter MED AACC wrote to House Energy and Commerce leaders raising concerns regarding the impact of H.R.3207, the Modernizing Laboratory Test Standards for Patients Act of 2011, on patient access to laboratory developed tests, test innovation, the ability of of differing health care providers to be able to conduct LDTs, and the potential regulatory costs associated with adopting the bill. HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-04-09T14:13:40.077000-04:00
1224196 THE HARRIS FIRM 9aaa2329-37bc-479b-aaff-b14a0000efe6 Q1 THE HARRIS FIRM 68376 DIRECT MESSAGE LAB 2012 first_quarter MED Regarding funding pertaining to software communication system for chronic disease management. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-04-09T15:11:05.097000-04:00
1224616 LATHAM & WATKINS LLP a644b84d-2092-40b1-ad3f-6c2d828472ea Q1 LATHAM & WATKINS LLP 22201 BOSTON SCIENTIFIC CORPORATION 2012 first_quarter MED Congressional oversight of the Food and Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-04-10T16:13:30.707000-04:00
1224929 AMERICAN COLLEGE OF CLINICAL PHARMACY 64b5a2ef-9c82-476d-a6a4-944a186f598f Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2012 first_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   61700 0 0 2012-04-11T11:31:16.407000-04:00
1225080 PARRY, ROMANI, DECONCINI & SYMMS 6ccf28a6-af12-44f0-816f-a43df84b26f1 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2012 first_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-04-11T14:35:38.287000-04:00
1225090 PARRY, ROMANI, DECONCINI & SYMMS 49e4e169-62c5-4c82-85b4-f76ce34d1f62 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2012 first_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2012-04-11T14:47:43.123000-04:00
1225105 THE PETRIZZO GROUP, INC. e1cecf85-bc63-45f6-993c-a69b93598b21 Q1 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2012 first_quarter MED Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases Advocated for support of House Dear Colleague Letter asking for signatures for additional NIH Funding Opposed H.R. 3699, which prohibits a federal agency from adopting, maintaining, continuing, or otherwise engaging in any policy, program, or other activity that: (1)causes, permits, or authorizes network dissemination of any private-sector research work without the prior consent of the publisher; or (2) requires that any actual or prospective author, or the author's employer, assent to such network dissemination. Organized Fred Hutchinson Cancer Research Center (FHCRC) event demonstrating the importance of the work FHCRC is doing in Washington State and the region HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-04-11T15:10:52.077000-04:00
1225109 PARRY, ROMANI, DECONCINI & SYMMS 05fb58da-d0d3-402d-bc76-db5c4d9fab98 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2012 first_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-04-11T15:11:54.920000-04:00
1225142 PARRY, ROMANI, DECONCINI & SYMMS 9b0d85c7-824e-42d4-8368-023a48f021d7 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2012 first_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-04-11T15:40:17.113000-04:00
1225150 PARRY, ROMANI, DECONCINI & SYMMS d7ddb76b-e396-4a4b-9476-e413f0eb9bf0 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2012 first_quarter MED Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-04-11T15:52:23.123000-04:00
1225349 THE PETRIZZO GROUP, INC. 3f1be42a-a024-4eba-a734-ce8813a073e4 Q1 THE PETRIZZO GROUP, INC. 305932 MVP SERVICE CORP. 2012 first_quarter MED Advocated concerns with negative consequences of the Patient Protection and Affordable Care Act (ACA), specifically 1) new taxes that will cause premium increases and rais cost of health care coverage; 2) cuts to Medicare Advantage funding; 3) weak individual mandate resulting in adverse selection; and 4) HHS proposed regulation that omits fraud and abuse prevention, concurrent review and costs associated with the federally-mandated ICD-10 program from health care quality improvement programs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-04-12T09:15:15.540000-04:00
1225548 PARRY, ROMANI, DECONCINI & SYMMS e02b0cd6-3b22-4508-8206-b281afa183fe Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2012 first_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 - Support funding for medical treatment for HIV positive patients. Support appropriate funding for the ADAP program. Continue appropriate funding for Chronic Care Special Needs clinics under Medicare. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-12T12:30:27.190000-04:00
1225803 DALRYMPLE & ASSOCIATES, LLC c4f98656-0d89-4d15-a88d-64fa11ed9a84 Q1 DALRYMPLE & ASSOCIATES, LLC 5073 DISCOVERY LABORATORIES 2012 first_quarter MED Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 16000   0 0 2012-04-12T15:19:47.033000-04:00
1225831 DALRYMPLE & ASSOCIATES, LLC 94d984ab-b0a2-416c-a538-4cb6f7753a35 Q1 DALRYMPLE & ASSOCIATES, LLC 5073 EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) 2012 first_quarter MED Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 46000   0 0 2012-04-12T15:32:57.997000-04:00
1225842 DALRYMPLE & ASSOCIATES, LLC 07ede6f6-8c29-4e62-8f41-c94e8af8d045 Q1 DALRYMPLE & ASSOCIATES, LLC 5073 SANOFI PASTEUR 2012 first_quarter MED Vaccine research and development legislation, funding, appropriations and oversight. Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office 46000   0 0 2012-04-12T15:38:01.903000-04:00
1225858 CHARLIE MCBRIDE ASSOCIATES 5c5566ba-f547-442e-aab8-d2a40e925338 Q1 CHARLIE MCBRIDE ASSOCIATES 24214 BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA 2012 first_quarter MED To monitor legislation affecting medical energy research and technology-based economic development HOUSE OF REPRESENTATIVES,SENATE 7200   0 0 2012-04-12T15:39:04.963000-04:00
1225994 BEN BARNES GROUP LP 49a1f40e-ae39-4b2d-94ed-6bdcbf56009d Q1 BEN BARNES GROUP LP 5415 HUNTSMAN CANCER INSTITUTE 2012 first_quarter MED Medical Research Funding HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2012-04-12T20:43:30.363000-04:00
1225997 BEN BARNES GROUP LP 76ea4abf-00a8-4cc2-ad33-13a850a9caf1 Q1 BEN BARNES GROUP LP 5415 OKLAHOMA RESEARCH MEDICAL FOUNDATION 2012 first_quarter MED Medical Research Funding HOUSE OF REPRESENTATIVES,SENATE 20100   0 0 2012-04-12T21:00:32.700000-04:00
1226070 DENNY MILLER ASSOCIATES e3b9698f-b159-4923-bdeb-9e5aa7d1fb0c Q1 DENNY MILLER ASSOCIATES 25328 CELL THERAPEUTICS 2012 first_quarter MED FDA appeal process for new drug applications. Prescription Drug and User Fee Act Reauthorization (no number), provisions relating to approval of new drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-13T10:03:25.597000-04:00
1226155 PALMETTO GROUP b9c30fc5-6b2b-4ad3-a06d-be136bf7af2e Q1 PALMETTO GROUP 18570 INTERNATIONAL AIDS VACCINE INITIATIVE 2012 first_quarter MED Federal Funding of AIDS vaccine S.1601 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2012 SENATE 42000   0 0 2012-04-13T10:21:58.797000-04:00
1226210 DENNY MILLER ASSOCIATES 0567497e-004f-4c0d-8e58-07c65433172b Q1 DENNY MILLER ASSOCIATES 25328 STB CORPORATION 2012 first_quarter MED Issues pertaining to the fiscal 2012 Defense appropriations bill (P.L. 112-74) and defense health program funding. HOUSE OF REPRESENTATIVES     0 0 2012-04-13T10:32:18.647000-04:00
1226436 ASSOCIATION OF UNIVERSITY CENTERS ON DISABLITIES e59d68d1-1521-42c7-ad90-f06f1dfa35cf Q1 ASSOCIATION OF UNIVERSITY CENTERS ON DISABLITIES 1728 ASSOCIATION OF UNIVERSITY CENTERS ON DISABLITIES 2012 first_quarter MED Intellectual and developmental disabilities research within the NIH Administration for Children & Families (ACF),Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE   40000 0 0 2012-04-13T12:21:46.057000-04:00
1226551 DEPARTMENT FOR PROFESSIONAL EMPLOYEES, AFL-CIO db3b0c01-8bab-4d49-a621-cad06dfca651 Q1 DEPARTMENT FOR PROFESSIONAL EMPLOYEES, AFL-CIO 12094 DEPARTMENT FOR PROFESSIONAL EMPLOYEES AFL-CIO 2012 first_quarter MED Antibiotics research and development. Commerce, Dept of (DOC),Executive Office of the President (EOP),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE,State, Dept of (DOS),Treasury, Dept of     0 0 2012-04-13T14:15:53.130000-04:00
1226568 KSCW, INC. 908559be-f3c9-4e70-86ef-1dbb2d91917a Q1 KSCW, INC. 21596 INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS 2012 first_quarter MED Legislation and regulation affecting the Medical device industry HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-04-13T14:19:04.003000-04:00
1226718 ASSN OF MEDICAL DEVICE REPROCESSORS 0071c9a7-458b-42d0-9d83-7f9f138b4639 Q1 ASSN OF MEDICAL DEVICE REPROCESSORS 291732 ASSN OF MEDICAL DEVICE REPROCESSORS 2012 first_quarter MED Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally. Initiated discussions on upcoming MDUFA reauthorization. Commerce, Dept of (DOC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. International Trade Commission (ITC)   20000 0 0 2012-04-13T15:38:06.860000-04:00
1227021 BEN BARNES GROUP LP 257d43c3-1268-49a0-8c24-cd60a4b1f767 Q1 BEN BARNES GROUP LP 5415 TEXAS A&M SYSTEM 2012 first_quarter MED Assist the Texas A&M System in pursuit of various research projects, general government relations Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2012-04-13T19:03:53.217000-04:00
1227154 FRANCIS EDWARD & CRONIN, INC. 7fdeec34-072b-48d8-9d7f-82264107f3f9 Q1 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2012 first_quarter MED Legislation and issues related to Alzheimer's Disease Research Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office 10000   0 0 2012-04-14T19:20:48.820000-04:00
1227551 THE CJR GROUP, INC. 501b3f05-1fd8-458e-9afd-cc1c7ad02e41 Q1 THE CJR GROUP, INC. 288293 STERIS CORPORATION 2012 first_quarter MED Biomedical issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-04-16T11:13:32.547000-04:00
1227566 THE CJR GROUP, INC. 20e58f83-d596-4fcd-8a39-7c479546486a Q1 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2012 first_quarter MED Medical issues relating to hospitals HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-04-16T11:17:39.907000-04:00
1227616 THE PETRIZZO GROUP, INC. 5b2c39e0-e357-4676-92f2-5abf75b5ab8b Q1 THE PETRIZZO GROUP, INC. 305932 SAGE THERAPEUTICS, INC. 2012 first_quarter MED Letter of Support for Innovation Grant Application Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-16T11:29:03.333000-04:00
1227643 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 5d875db2-0dbc-4fd8-8fdc-a515379e54cf Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2012 first_quarter MED Research and public health programs in epilepsy. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2012-04-16T11:42:16.477000-04:00
1227863 AMERICAN ASSOCIATION FOR CANCER RESEARCH d2ab3b88-45df-4418-a9c3-c797a2e25587 Q1 AMERICAN ASSOCIATION FOR CANCER RESEARCH 400601833 AMERICAN ASSOCIATION FOR CANCER RESEARCH 2012 first_quarter MED drug shortage HOUSE OF REPRESENTATIVES,SENATE   25000 0 0 2012-04-16T13:00:58.913000-04:00
1227883 MEHLMAN CONSULTING, INC. c9bd38de-87f6-41f7-867d-2ae233e2bdfc Q1 MEHLMAN CONSULTING, INC. 284950 NATIONAL VENTURE CAPITAL ASSOCIATION 2012 first_quarter MED FDA reform: Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs. H.R. 4132, Faster Access to Specialized Treatments (FAST) Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act; H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011; S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012 Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of 60000   0 0 2012-04-16T13:06:09.617000-04:00
1227908 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c9cc548e-2c69-4add-a243-572b710386e6 1A CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2012 first_quarter MED Research and public health programs in epilepsy. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2012-04-16T13:14:23.227000-04:00
1227981 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e78c4805-ba10-4012-bc77-6f2616a84829 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 STATE UNIVERSITY SYSTEM OF FLORIDA 2012 first_quarter MED Appropriations and Authorization legislation for FY 2013 in health care Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE 70000   0 0 2012-04-16T13:51:58.323000-04:00
1227994 PARALYZED VETERANS OF AMERICA ae9ba712-f51c-47fc-b4f5-d7faa15597d0 Q1 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2012 first_quarter MED Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   92927 0 0 2012-04-16T13:54:01.277000-04:00
1228049 THE PETRIZZO GROUP, INC. 72592ccf-07b5-4361-8c49-3e42b5b5fa18 Q1 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2012 first_quarter MED Advocated for legislation to create pediatric research hubs to maximize the impact of existing pediatric research capacity and boost funding for research benefitting children. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-16T14:08:23.547000-04:00
1228058 THOMPSON HINE LLP 3533108b-4144-4e89-8908-72988d9de630 Q1 THOMPSON HINE LLP 38051 TEXAS BIOMEDICAL RESEARCH INSTITUTE 2012 first_quarter MED Legislative and regulatory matters regarding the use of chimpanzees in biomedical research (i.e., the Great Ape Protection and Cost Savings Act and possible "endangered species" designation for chimpanzees by the U.S. Fish and Wildlife Service). HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-16T14:11:26.377000-04:00
1228102 POLICY DIRECTIONS INC. dd56ff6f-8f88-4164-a1af-62d4292b1f23 Q1 POLICY DIRECTIONS INC. 31747 BAYLOR COLLEGE OF MEDICINE 2012 first_quarter MED S. 606 and HR 3059- Creating Hope Act of 2011 - issues related to neglected tropical disease research and treatment. HR 528 - Neglected Infections of Impoverished Americans Act of 2011. House & Senate Farm Bill (No Bill), Research Title HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-16T14:20:40.643000-04:00
1228155 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7f9f0a66-6fe6-45f8-8e55-03b3ea30421c Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2012 first_quarter MED Hemophilia research, prevention, surveillance and service programs and issues. HR1919 Bleeding Disorders Screening Awareness and Further Education Act of 2011 Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2012-04-16T14:48:02.390000-04:00
1228275 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. eb8f33e3-2e40-4f9a-a9be-d07c7fa61943 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION OF AMERICA'S BLOOD BANKS 2012 first_quarter MED Blood safety and management issues. HHS Advisory Committee on Blood Safety and Availability. Research related to Biovigilance. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-04-16T15:28:54.543000-04:00
1228320 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 10b6347b-c0d0-42a1-96a5-1656f01c1fc9 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2012 first_quarter MED Research in hematology. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-04-16T15:44:13.423000-04:00
1228340 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9b523eaf-fc2d-4a7d-9829-71a40388b56e Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2012 first_quarter MED No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, Tuberous Sclerosis No Bill #, Defense Appropriations, FY 2013 Defense health programs, Tuberous Sclerosis Complex Research Program Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2012-04-16T15:50:22.067000-04:00
1228446 SANOFI US SERVICES INC. a1c80ccf-b945-4b65-a040-94110532e153 Q1 SANOFI US SERVICES INC. 56838 SANOFI US SERVICES INC 2012 first_quarter MED Reauthorization of the Prescription Drug User Fee Act (PDUFA) HOUSE OF REPRESENTATIVES,SENATE   750000 0 0 2012-04-16T16:42:19.697000-04:00
1228974 MEHLMAN CONSULTING, INC. 920e94be-5bf2-4678-b141-b39090e5ad6b Q1 MEHLMAN CONSULTING, INC. 284950 AMERICAN CLINICAL LABORATORY ASSOCIATION 2012 first_quarter MED Health reform law implementation issues including application of medical device tax to clinical laboratory tests and laboratory fee schedule. In-office ancillary services exception to Stark Law. H.R. 3207, The Modernizing Laboratory Test Standards for Patients Act. H.R. 3630, The Middle Class Tax Relief and Job Creation Act of 2012 (Became PL 112-96 on 2/22/12). Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 60000   0 0 2012-04-17T09:51:04.570000-04:00
1229363 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 61de16d6-97f9-41e6-8ffa-a4fa23873e3c Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 SAGE PUBLICATIONS, INC. 2012 first_quarter MED HR4004, S.2096, Federal Research Public Access Act; National Institutes of Health Open Access policy No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, NIH Open Access Policy, Department of Education Title II Funding HR3699, Research Works Act No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-17T12:40:12.147000-04:00
1229375 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8b5656fd-d806-4566-a300-798aef767ee7 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION 2012 first_quarter MED No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research No Bill #, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2012-04-17T12:43:18.383000-04:00
1229386 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 46db7999-a353-46d6-914c-a808d390cc2f Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION FOR MOLECULAR PATHOLOGY 2012 first_quarter MED Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1249, America Invents Act; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE 30000   0 0 2012-04-17T12:48:24.853000-04:00
1229425 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 00d8e56b-fe54-463b-af69-1912654e05e2 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 INTERNATIONAL MYELOMA FOUNDATION 2012 first_quarter MED HR 2746 Cancer Drug Coverage Parity Act; HR 2245/S.296 Preserving Access to Lifesaving Medications Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-04-17T13:08:40.263000-04:00
1229429 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2db75f22-fb21-418f-8e2d-515eaa20363a Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ONYX PHARMACEUTICALS 2012 first_quarter MED Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages. HR 4132 Faster Access to Specialized Treatments (FAST) Act; S.2113 Transforming the Regulatory Environment to Accellerate Access to Treatments (TREAT) Act; HR 2245/S.296: Preserving Access to Lifesaving Medications Act; No Bill #: Prescription Drug User Fee Act reauthorization Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-04-17T13:10:42.267000-04:00
1229433 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 91b48e7c-12c9-426e-9529-242db3cbc019 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TETHYS BIOSCIENCE 2012 first_quarter MED Regulation and reimbursement of laboratory developed tests. No Bill #: BETTER Patient Care Act Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-17T13:13:45.063000-04:00
1229626 MEHLMAN CONSULTING, INC. 023d15e9-eef8-4259-8d4b-a37281ed2e86 Q1 MEHLMAN CONSULTING, INC. 284950 MAYO CLINIC 2012 first_quarter MED NIH appropriations Clinical laboratory reimbursement Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-17T14:34:10.613000-04:00
1229723 SRI INTERNATIONAL ead71cc1-a354-4af7-959a-82d0f7949bca Q1 SRI INTERNATIONAL 90990 SRI INTERNATIONAL 2012 first_quarter MED Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 (HR 2405) FY13 House and Senate Labor/HHS/Education Appropriations HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2012-04-17T14:59:44.323000-04:00
1229733 OGR d9ea4f47-ae6e-4020-93c7-808835767a42 Q1 OGR 48827 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) 2012 first_quarter MED Medical Device User Fee Act and related issues HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-17T15:00:46.697000-04:00
1229891 WASHINGTON UNIVERSITY IN ST. LOUIS b8651b0c-65d7-428c-9cec-531462294f7f Q1 WASHINGTON UNIVERSITY IN ST. LOUIS 40031264 WASHINGTON UNIVERSITY IN ST LOUIS 2012 first_quarter MED General advocacy for NIH research, genomics research, and improved conflict of interest policies. Advocacy in support of clear, productive federal stem cell research guidelines HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2012-04-17T15:55:17.783000-04:00
1229951 THE NORMANDY GROUP, LLC 3577e297-a41b-4986-9b72-5ca56bea34cd Q1 THE NORMANDY GROUP, LLC 306636 CENTER FOR DISEASE DETECTION, LLC 2012 first_quarter MED Seek assistance from Dept. of Commerce, Dept. of State in effort to expand medical testing in Latin America. Commerce, Dept of (DOC),Job Corps,State, Dept of (DOS) 30000   0 0 2012-04-17T16:07:19.910000-04:00
1230135 PARRY, ROMANI, DECONCINI & SYMMS e820c22a-f43b-4fd8-a3ad-8e60f00fe5d1 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) 2012 first_quarter MED General discussions regarding the rauthorization of the Prescription Drug User Fee Act (PDUFA); and education and awareness of vaccine production and infrastructure needs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-17T16:46:36.223000-04:00
1230201 FAEGRE DRINKER BIDDLE & REATH LLP f70986f6-57ad-48ff-b02e-5462cfb7e71f Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2012 first_quarter MED Public Health Programs for Infectious and Tropical Disease; CDC Infection and Vector Borne Disease and Global Health Programs; Department of Defense Tropical Medicine Research; National Institutes of Health Tropical Medicine Programs. Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-17T17:02:07.133000-04:00
1230206 FAEGRE DRINKER BIDDLE & REATH LLP 8207daac-6afc-4625-b8a3-ea8c699b3d7e Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 CHILDREN'S CARDIOMYOPATHY FOUNDATION, INC. 2012 first_quarter MED H.R. 3625/S.2124 - The Cardiomyopathy Health, Education, Awareness, Risk Assessment, and Training in the Schools Act; Development of a Registry on Sudden Cardiac Arrest. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-04-17T17:04:10.527000-04:00
1230236 FAEGRE DRINKER BIDDLE & REATH LLP 08a8e589-e7bb-4dd3-b206-dad763618b9c Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA 2012 first_quarter MED Public Health and Medical Research Programs for Neglected and Infectious and Pediatric HIV/AIDS Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act; S. 606 - Creating Hope Act of 2011. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-04-17T17:09:25.623000-04:00
1230300 FAEGRE DRINKER BIDDLE & REATH LLP 9a08f9f7-483b-4764-af41-819acc203ac7 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 NATIONAL PSORIASIS FOUNDATION 2012 first_quarter MED H.R. 2033/S.1107 - Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011; Psoriasis Data Collection. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-04-17T17:28:53.143000-04:00
1230346 FAEGRE DRINKER BIDDLE & REATH LLP 73330b26-d538-43a1-966b-a0d7fefd9a4f Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 OVARIAN CANCER NATIONAL ALLIANCE 2012 first_quarter MED Ovarian Cancer Research and Awareness; Implementation of Johanna's Law. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-04-17T17:41:12.713000-04:00
1230370 FAEGRE DRINKER BIDDLE & REATH LLP 1f68f71f-890c-43b2-8271-92c0cdeac6ae Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREECLAMPSIA FOUNDATION 2012 first_quarter MED FY 2013 Labor, Health and Human Services, and Education Appropriations Bill - Preeclampsia Research Issues; National Health Calendar Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2012-04-17T17:50:24.120000-04:00
1230392 FAEGRE DRINKER BIDDLE & REATH LLP 047df64a-1565-4f80-97e6-c2283e2caa4b Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREVENT BLINDNESS 2012 first_quarter MED Eye Disease and Vision Health; Treatment and Prevention of Blindness and Vision Loss. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-17T17:52:31.077000-04:00
1230412 FAEGRE DRINKER BIDDLE & REATH LLP 99ddaf5d-854c-4ed1-ac38-66c5da52a913 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 RIVERAIN MEDICAL 2012 first_quarter MED Increasing awareness of lung cancer and making it a public health priority Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-17T17:57:38.153000-04:00
1230419 FAEGRE DRINKER BIDDLE & REATH LLP f1ca1478-ad54-493e-bdbb-e305173df83c Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 SPINA BIFIDA ASSOCIATION 2012 first_quarter MED Spina Bifida Research and Awareness and Access to Care; Folic Acid Fortification. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-17T17:58:39.860000-04:00
1230460 OGR 3cfc9d3c-d966-4da2-86b0-befe2b6c8024 Q1 OGR 48827 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2012 first_quarter MED Issues related to insuring access to over-the-counter drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-17T18:46:56.503000-04:00
1230790 SQUIRE PATTON BOGGS a2ea0e8a-e51c-4c6e-8570-c8143cd7d571 Q1 SQUIRE PATTON BOGGS 30906 MELA SCIENCES, INC. 2012 first_quarter MED FDA regulatory procedures with respect to melanoma detection systems. Food & Drug Administration (FDA) 10000   0 0 2012-04-18T06:48:58.157000-04:00
1231383 GOLDBUG STRATEGIES LLC ea9f36d3-c180-48d2-9e0f-7e5ed019edba Q1 GOLDBUG STRATEGIES LLC 400701094 COALITION FOR 21ST CENTURY MEDICINE 2012 first_quarter MED FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2012-04-18T11:05:00.567000-04:00
1231416 GOLDBUG STRATEGIES LLC 1def08d1-2ee3-4c34-b07b-e93f08786563 Q1 GOLDBUG STRATEGIES LLC 400701094 GENOMIC HEALTH INC. 2012 first_quarter MED FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. HR 3207 Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-04-18T11:11:14.740000-04:00
1231610 TURNER & GOSS LLP 585919ec-d229-48c0-b23e-51b5c462365b Q1 TURNER & GOSS LLP 316310 CYSTIC FIBROSIS FOUNDATION 2012 first_quarter MED Legislation reauthorizing the Prescription Drug User Fee Act S.2281/HR 4156, Expanding and Promoting Expertise in Review of Rare Treatments Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-04-18T11:38:40.420000-04:00
1231769 TCH GROUP, LLC e56cd330-a490-4914-9d07-d778f9fbf61b Q1 TCH GROUP, LLC 51478 SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) 2012 first_quarter MED General discussion regarding the reauthorization of the Prescription Drug User Fee Act (PDUFA) HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-04-18T11:56:50.163000-04:00
1231989 NATIONAL GROUP, LLP 02217219-07c7-4bac-8917-534994e125b7 1T NATIONAL GROUP, LLP 66090 PROVIDENCE HEALTH SYSTEM 2012 first_quarter MED Medical research and equipment funding Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 1 2012-04-18T12:28:22.270000-04:00
1232034 FEDERAL SOLUTIONS, LLC 63d882fc-c83d-4e82-9ff8-dbaa7abbdff7 Q1 FEDERAL SOLUTIONS, LLC 311371 JACKSONVILLE STATE UNIVERSITY 2012 first_quarter MED Labor/HHS/Education Appropriations Bill 2012: Provisions relating to disease research, education, and development HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-04-18T12:40:40.507000-04:00
1232052 FEDERAL SOLUTIONS, LLC 9f4194c1-6029-4836-abff-ebc4fd8612a6 Q1 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2012 first_quarter MED Labor/HHS/Education Appropriations Bill, 2012: Provisions relating to disease research Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2012-04-18T12:44:47.760000-04:00
1232133 HARRISON RIVARD DUNCAN & BUZZETT, CHTD. 8d8f219e-4adf-4477-8c65-2e8181b7afa2 Q1 HARRISON RIVARD DUNCAN & BUZZETT, CHTD. 72257 HCA HEALTHCARE 2012 first_quarter MED Health and Medical Issues       0 0 2012-04-18T12:59:15.187000-04:00
1232377 FAEGRE BAKER DANIELS CONSULTING 6e03b9b2-aa99-46db-82a9-f85f9c567e40 Q1 FAEGRE BAKER DANIELS CONSULTING 34158 COUNCIL FOR AMERICAN MEDICAL INNOVATION (CAMI) 2012 first_quarter MED Funding of the FDA & NIH, Regulatory System at the FDA Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-04-18T13:50:12.690000-04:00
1232598 W STRATEGIES, LLC 1758b03e-847e-49d9-abde-9caeb2f3b6e6 Q1 W STRATEGIES, LLC 400605842 23ANDME, INC. 2012 first_quarter MED Issues relating to regulation of Direct to Consumer Genetic Testing and education and outreach regarding genetic testing and personalized medicine. H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011. Issues related to genetics and Parkinsons' Disease HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-18T14:15:52.570000-04:00
1232613 FOLEY & LARDNER LLP 58b8ff40-f7c4-4442-918c-ea777e162ca4 Q1 FOLEY & LARDNER LLP 15042 FLUGEN, INC. 2012 first_quarter MED Funding for vaccine research and development and vaccine delivery product. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-04-18T14:17:57.527000-04:00
1232628 GRAY & OSCAR, LLC (FORMERLY BOB GRAY, LLC) 4eed60ba-ab96-49cf-a9fb-d66216fa8833 Q1 GRAY & OSCAR, LLC (FORMERLY BOB GRAY, LLC) 33124 IMX MEDICAL MANAGEMENT SERVICES 2012 first_quarter MED Informed Members of the Pennsylvania Congressional Delegation regarding IMX's efforts to receive consideration of their medical evaluation services with the Department of Veterans Affairs, Department of Defense, and the Department of Labor. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE     0 0 2012-04-18T14:19:02.967000-04:00
1232714 FOLEY & LARDNER LLP 7151b6cc-03c1-423d-b407-dbd6695259bf Q1 FOLEY & LARDNER LLP 15042 PHOENIX NUCLEAR LABS LLC 2012 first_quarter MED Legislation to promote development of radio-isotopes for medical diagnostics and therapy Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-04-18T14:27:40.423000-04:00
1232759 DIALYSIS PATIENT CITIZENS 1c455f67-fe03-44d4-9427-ceade82780c7 Q1 DIALYSIS PATIENT CITIZENS 400460287 DIALYSIS PATIENT CITIZENS 2012 first_quarter MED Importance of anemia management for ESRD patients Prioritizing patient role in infection prevention efforts at dialysis facilities Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA),White House Office   75000 0 0 2012-04-18T14:32:00.627000-04:00
1232844 FAEGRE BAKER DANIELS CONSULTING cf337e7c-d908-4c16-9723-d08d9571aec2 Q1 FAEGRE BAKER DANIELS CONSULTING 34158 ARTHRITIS FOUNDATION 2012 first_quarter MED NIH Research, CDC Public Health, Medicare, Children's Health HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-04-18T14:41:44.693000-04:00
1232923 WHITMER & WORRALL, LLC 9411533f-61d0-452d-a0b6-a33ce5f2da6c Q1 WHITMER & WORRALL, LLC 292892 NEURO KINETICS 2012 first_quarter MED Issues related to Traumatic Brain Injury (TBI). HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-04-18T14:50:21.367000-04:00
1232992 FAEGRE BAKER DANIELS CONSULTING 2f1fb43b-56c7-413d-9a6e-1a420f5a84ae Q1 FAEGRE BAKER DANIELS CONSULTING 34158 COALITION FOR EXCELLENCE IN MEDICATION MONITORING 2012 first_quarter MED Medicare & Medicaid Coverage & Payment HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-18T14:56:48.167000-04:00
1233120 FIRST STRATEGIC e13f4626-97ff-40b2-a3d4-51620d451260 Q1 FIRST STRATEGIC 91091 TRANSLATIONAL GENOMICS RESEARCH INSTITUTE 2012 first_quarter MED The Creating Hope Act - issues regarding drug development for pediatric rare diseases. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-18T15:13:41.250000-04:00
1233156 PRIME POLICY GROUP 9ff4055a-6184-4311-a470-cbaaf54dc563 Q1 PRIME POLICY GROUP 400532589 VERAX BIOMEDICAL, INC. 2012 first_quarter MED Blood Safety HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-18T15:17:56.907000-04:00
1233223 FIRST STRATEGIC 827c890e-8d4e-4263-9bc7-a133875a529d Q1 FIRST STRATEGIC 91091 PHOENIX CHILDREN'S HOSPITAL 2012 first_quarter MED Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-18T15:26:30.800000-04:00
1233239 FAEGRE BAKER DANIELS CONSULTING 6becab38-2fee-4784-afd5-f5c3bda6213d Q1 FAEGRE BAKER DANIELS CONSULTING 34158 LEARNING & EDUCATION ACADEMIC RESEARCH NETWORK 2012 first_quarter MED National Institute of Child Health & Human DevelopmentResearch Grants Education, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE 20000   0 0 2012-04-18T15:27:35.300000-04:00
1233329 PHOENIX CHILDREN'S HOSPITAL 7a7c607d-030b-433f-a005-345bbbdf8763 Q1 PHOENIX CHILDREN'S HOSPITAL 400381743 PHOENIX CHILDREN'S HOSPITAL 2012 first_quarter MED Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS. HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2012-04-18T15:38:12.447000-04:00
1233639 ASSOCIATION OF AMERICAN UNIVERSITIES 0a9323c6-1506-4d6a-9f50-35931616d38a 1T ASSOCIATION OF AMERICAN UNIVERSITIES 40048368 ASSOCIATION OF AMERICAN UNIVERSITIES 2012 first_quarter MED TBD NIH Funding appropriations and effect on higher education institutions HOUSE OF REPRESENTATIVES,SENATE   28661 0 1 2012-04-18T16:29:21.557000-04:00
1233719 VENABLE LLP d08b5782-ddb9-49a5-a2b1-338e0c9ee55b Q1 VENABLE LLP 39941 AMPHASTAR PHARMACEUTICALS INC. 2012 first_quarter MED Primatene Mist Sunset Date Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-04-18T16:42:04.953000-04:00
1233785 ELECTROCHEMICAL OXYGEN CONCEPTS, INC. DBA EO2 CONCEPTS 3c5f571e-269e-4985-b056-e82d3122e731 Q1 ELECTROCHEMICAL OXYGEN CONCEPTS, INC. DBA EO2 CONCEPTS 400804407 ELECTROCHEMICAL OXYGEN CONCEPTS, INC. DBA EO2 CONCEPTS 2012 first_quarter MED No lobbying activity. HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2012-04-18T16:56:50.223000-04:00
1233884 INFECTIOUS DISEASES SOCIETY OF AMERICA 26738e9f-241e-4686-b0c0-9690bc1d91cd Q1 INFECTIOUS DISEASES SOCIETY OF AMERICA 54836 INFECTIOUS DISEASES SOCIETY OF AMERICA 2012 first_quarter MED Medical liability; antimicrobial resistance research; infectious diseases product research and development; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; and point-of-care diagnostic tests. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID)   103264 0 0 2012-04-18T17:22:50.410000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1466.774ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API